فصلنامه علمی پژوهشی بهداشت در عرصه

1- United Nations. Department of economic and social affairs, population division. World Population Prospects 2024: Summary of Results. New York: United Nations; 2024. Available from: https://population.un.org/wpp/. Accessed Jan 15, 2025.

2- WHO. World report on ageing and health.. Available from: https://www.who.int/publications/i/item/9789241565042. Accessed 2015 Sep 29.

3- Statistical Centre of Iran. Population projections (updated 2024). Tehran: Statistical Centre of Iran; 2024. Available from: https://www.amar.org.ir. Accessed 2025 Jan 15.

4- Nekouyan Jazi S, Ghaedrahmati S. Population aging and housing demand in Shahin Shahr, Iran: Strategies for sustainable planning toward 2037. International Journal of Housing Markets and Analysis 2025:1-27. Doi: 10. 1108/ IJHMA- 08-2025-0179

5- Hazar N, Jokar M, Namavari N, Hosseini S, Rahmanian V. An updated systematic review and meta-analysis of the prevalence of type 2 Diabetes in Iran, 1996–2023. Frontiers in Public Health 2024; 12:1322072. Doi: 10. 3389/ fpubh. 2024. 1322072.

6- Namjoo S, Mirzaei M, Foroughan M, Harouni GG, Aboubakri O. Prevalence and determinants of depression, anxiety and stress among the Iranian older people with type 2 Diabetes. Journal of Renal Injury Prevention 2022; 11(2):e10. Doi: 10.34172/jrip.2022.10.

7- Norouzi S, Moradi L, Esmaeili M, Pourshams M. Frequency of generalized anxiety disorder and depression in elderly patients with type II Diabetes referred to the Diabetes clinic in 2021. Journal of Diabetes Nursing 2023; 11(1):2069-85 )In Persian(.

8- Abualhamael SA, Baig M, Alghamdi W, Gazzaz ZJ, Al-Hayani M, Bazi A. Quality of life, stress, anxiety and depression and associated factors among people with type 2 diabetes mellitus in Western region Saudi Arabia. Frontiers in Psychiatry 2024; 14:1282249. Doi: 10. 3389/ fpsyt. 2023. 1282249.

9- Shirisha J, Priyanka S, Devulapally Y, Madhuri NK. Assessment of depression, anxiety, and stress in type 2 Diabetic patients: A case-control study. National Journal of Physiology, Pharmacy and Pharmacology 2023; 13(6):1171-73 )In Persian(.

10- Kyrou I, Tsigos C. Stress hormones: Physiological stress and regulation of metabolism. Current Opinion in Pharmacology 2009; 9(6):787-93.

11- Chrousos GP. Stress and disorders of the stress system. Nature Reviews Endocrinology 2009; 5(7):374–81.

12- Fanelli G, Raschi E, Hafez G, Matura S, Schiweck C, Poluzzi E, et al. The interface of depression and diabetes: treatment considerations. Translational psychiatry. 2025;15(1):22.

13- McInerney AM, Lindekilde N, Nouwen A, Schmitz N, Deschênes SS. Diabetes distress, depressive symptoms, and anxiety symptoms in people with type 2 Diabetes: A network analysis approach to understanding comorbidity. Diabetes Care 2022; 45(8):1715-23.

14- Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with Diabetes: A systematic review. Journal of Psychosomatic Research 2002; 53(6):1053-60.

15- Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. Journal of Psychology 2005; 1(4): 335-43 )In Persian(.

16- Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behaviour Research and Therapy 1995; 33(3): 335-43.

17- Fatmawati F, Suswani A, Nurlina N. Comparison of the rate of depression in early and late elderly women with Diabetes mellitus. Journal Penelitian Pendidikan IPA 2023; 9(7):5329-32.

18- Hosseini SR, Amini N, Bijani A, Ghadimi R, Ahangari N, Faramarzi M. Trends in depressive symptoms and the factors affecting them in older adults: A prospective cohort study. Salmand: Iranian Journal of Ageing 2025; 20(3):422-37 (In Persian).

19- Gorrochategi MP, Munitis AE, Santamaria MD, Etxebarria NO. Stress, anxiety, and depression in people aged over 60 in the COVID-19 outbreak in a sample collected in Northern Spain. The American Journal of Geriatric Psychiatry 2020; 28(9):993–98.

20- Moayedi F, Zare Sh , Nikbakht M. Anxiety and depression in Diabetic patient referred to Bandar Abbas Diabetes clinic. Hormozgan Medical Journal 2014; 18(1):65–71 (In Persian).

21- Hoogendoorn CJ, Shapira A, Roy JF, Walker EA, Cohen HW, Gonzalez JS. Depressive symptom dimensions and medication non-adherence in suboptimally controlled type 2 diabetes. Journal of Diabetes and its Complications 2019; 33(3):217-22.